Table 3.

Relationship between cardiac concentricity and non-hypertensive pathway measures in schizophrenia.

	Whole sample					Schizophrenia sample					Supplementary Figs.
	R2	F (48, 1)	β for concentricity	p	BH p	R2	F (24,1)	β for concentricity	p	BH p
Log(adiponectin)	0.20	11.70	−1.16	0.001	0.01	0.15	4.12	−0.91	0.05	0.378	2
Log(triglycerides)	0.11	6.05	1.07	0.02	0.06	0.07	1.77	0.82	0.20	0.392	3
Log(endothelin-1)	0.10	5.12	0.50	0.03	0.06	0.05	1.38	0.39	0.25	0.392	4
Log(ALP)	0.02	1.22	0.48	0.27	0.38	0.03	0.67	0.26	0.42	0.490	5
Log(HDL)	0.06	3.30	−0.40	0.08	0.13	0.05	1.39	−0.31	0.25	0.392	6
Log(hsCRP)	<0.01	0.08	0.30	0.78	0.78	<0.01	0.06	0.25	0.81	0.810	7
Log(fasting glucose)	0.01	0.60	0.07	0.44	0.51	0.05	1.24	−0.13	0.28	0.392	8

Simple linear regression analysis was used to test the association between significantly altered non-hypertensive pathway measures and participants’ concentricity values.

ALP alkaline phosphatase, hsCRP high-sensitivity C-reactive protein, HDL high-density lipoprotein, BH Benjamini and Hochberg.